DanCann Pharma Balance Sheet Health
Financial Health criteria checks 3/6
DanCann Pharma has a total shareholder equity of DKK6.3M and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK20.5M and DKK14.2M respectively.
Key information
0%
Debt to equity ratio
DKK 0
Debt
| Interest coverage ratio | n/a |
| Cash | -DKK 706.00k |
| Equity | DKK 6.35m |
| Total liabilities | DKK 14.18m |
| Total assets | DKK 20.53m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DAN's short term assets (DKK7.3M) do not cover its short term liabilities (DKK14.2M).
Long Term Liabilities: DAN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DAN is debt free.
Reducing Debt: DAN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if DAN has enough cash runway based on its current free cash flow.
Forecast Cash Runway: DAN has less than a year of cash runway if free cash flow continues to grow at historical rates of 8.5% each year.